These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 18182707

  • 1. Assessment of mycophenolate mofetil for treatment of frequently relapsing nephrotic syndrome in children.
    Yi ZW, Dang XQ, He QN, Wu XC, Cao Y, Huang DL, He XJ, Mo SH.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 32(6):938-40. PubMed ID: 18182707
    [Abstract] [Full Text] [Related]

  • 2. [Mycophenolate mofetil in the treatment of primary nephrotic syndrome].
    Zhao M, Chen X, Chen Y, Liu Z, Liu Y, Lu F, Zhang Y, Wang H.
    Zhonghua Yi Xue Za Zhi; 2001 May 10; 81(9):528-31. PubMed ID: 11809115
    [Abstract] [Full Text] [Related]

  • 3. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
    Li X, Tian J, Wu J, He Q, Li H, Han F, Li Q, Chen Y, Ni Q, Chen J.
    Clin Ther; 2009 Apr 10; 31(4):741-50. PubMed ID: 19446147
    [Abstract] [Full Text] [Related]

  • 4. [Mycophenolate mofetil versus cyclosporine A in children with primary refractory nephrotic syndrome].
    Geng HY, Ji LN, Chen CY, Tu J, Li HR, Bao R, Lin Y.
    Zhonghua Er Ke Za Zhi; 2018 Sep 02; 56(9):651-656. PubMed ID: 30180402
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
    Wang J, Mao J, Chen J, Fu H, Shen H, Zhu X, Liu A, Shu Q, Du L.
    Nephrology (Carlton); 2016 Jan 02; 21(1):21-7. PubMed ID: 26697959
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study Group.
    Hogg RJ, Fitzgibbons L, Bruick J, Bunke M, Ault B, Baqi N, Trachtman H, Swinford R.
    Clin J Am Soc Nephrol; 2006 Nov 02; 1(6):1173-8. PubMed ID: 17699344
    [Abstract] [Full Text] [Related]

  • 7. [A prospective multicenter clinical control trial on treatment of refractory nephrotic syndrome with mycophenolate mofetil in children].
    Yi ZW, Wu XC, Xu H, Zhou LJ, Wu YB, Feng SP, Zhou JH, Yang Q, Zhu GH, Liu AM, Wei MJ, Yu L, Zeng ZF.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct 02; 10(5):575-8. PubMed ID: 18947472
    [Abstract] [Full Text] [Related]

  • 8. Clinical observations of mycophenolate mofetil therapy in refractory primary nephrotic syndrome.
    Zhao M, Chen X, Chen Y, Liu Z, Liu Y, Lu F, Zhang Y, Wang H.
    Nephrology (Carlton); 2003 Jun 02; 8(3):105-9. PubMed ID: 15012724
    [Abstract] [Full Text] [Related]

  • 9. Mycophenolate mofetil for treatment of idiopathic nephrotic syndrome in children.
    Nickavar A, Safarzadeh AE, Sotoudeh K, Otukesh H, Hooman N.
    Iran J Kidney Dis; 2012 Sep 02; 6(5):346-9. PubMed ID: 22976259
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y.
    Pediatr Nephrol; 2015 Jul 02; 30(7):1121-9. PubMed ID: 25773534
    [Abstract] [Full Text] [Related]

  • 11. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
    Przegl Lek; 2006 Jul 02; 63 Suppl 3():44-8. PubMed ID: 16898486
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
    Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
    Kidney Int; 2017 Jul 02; 92(1):248-257. PubMed ID: 28318625
    [Abstract] [Full Text] [Related]

  • 13. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
    Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L.
    Nephrology (Carlton); 2015 Jan 02; 20(1):18-24. PubMed ID: 25312783
    [Abstract] [Full Text] [Related]

  • 14. [Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children].
    Ogarek I, Szczęsny-Choruz E, Wierzchowska-Słowiaczek E, Kwinta-Rybicka J, Stec Z, Moczulska A, Wilkosz K, Drożdż D.
    Pol Merkur Lekarski; 2018 Apr 23; 44(262):192-195. PubMed ID: 29775447
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome.
    Al-Akash S, Al-Makdama A.
    Ann Saudi Med; 2005 Apr 23; 25(5):380-4. PubMed ID: 16270759
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil in children with multidrug-resistant nephrotic syndrome.
    Bayazit AK, Noyan A, Cengiz N, Anarat A.
    Clin Nephrol; 2004 Jan 23; 61(1):25-9. PubMed ID: 14964454
    [Abstract] [Full Text] [Related]

  • 17. Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil.
    Chandra M, Susin M, Abitbol C.
    Pediatr Nephrol; 2000 Mar 23; 14(3):224-6. PubMed ID: 10752763
    [Abstract] [Full Text] [Related]

  • 18. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
    Okada M, Sugimoto K, Yagi K, Yanagida H, Tabata N, Takemura T.
    Pediatr Int; 2007 Dec 23; 49(6):933-7. PubMed ID: 18045300
    [Abstract] [Full Text] [Related]

  • 19. Clinical efficacy of mycophenolate mofetil versus levamisole therapy in frequently relapsing and steroid dependent childhood nephrotic syndrome - A retrospective comparative analysis.
    Sharma S, Kalra S, Shukla S, Sharma P.
    Nephrology (Carlton); 2022 Sep 23; 27(9):758-762. PubMed ID: 35619554
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
    Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A.
    Kidney Int; 2019 Jan 23; 95(1):210-218. PubMed ID: 30497684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.